Free Trial

Centene Corporation $CNC Holdings Lessened by Private Management Group Inc.

Centene logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Private Management Group cut its Centene stake by 97.7% in the third quarter, selling 403,505 shares and retaining 9,669 shares worth about $601,000.
  • Centene reported quarterly EPS of $0.58, beating the $0.10 consensus estimate, while revenue of $50.65 billion also topped expectations; revenue rose 1.9% year over year.
  • Analysts’ consensus rating was Hold, with an average price target of $73.80; nine analysts rated the stock Buy, 11 Hold, and one Sell.
  • MarketBeat previews top five stocks to own in December.

Private Management Group Inc. decreased its position in shares of Centene Corporation (NYSE:CNC - Free Report) by 97.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,669 shares of the company's stock after selling 403,505 shares during the quarter. Private Management Group Inc.'s holdings in Centene were worth $601,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Centene during the 2nd quarter valued at about $2,660,422,000. Wellington Management Group LLP lifted its holdings in shares of Centene by 423.0% in the 2nd quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company's stock valued at $853,805,000 after buying an additional 10,757,914 shares during the period. Bank of America Corp DE purchased a new stake in shares of Centene in the second quarter worth about $285,713,000. Deutsche Bank AG acquired a new stake in Centene during the second quarter worth about $257,279,000. Finally, Legal & General Group Plc acquired a new stake in Centene during the second quarter worth about $244,463,000. Hedge funds and other institutional investors own 93.63% of the company's stock.

Insider Activity at Centene

In other news, General Counsel Christopher Koster sold 56,500 shares of the business's stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total value of $3,779,850.00. Following the completion of the sale, the general counsel directly owned 248,854 shares in the company, valued at $16,648,332.60. The trade was a 18.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is owned by company insiders.

Analyst Ratings Changes

CNC has been the subject of several recent research reports. Jefferies Financial Group reiterated a "hold" rating and set a $69.00 price target on shares of Centene in a research report on Thursday, October 29th. Bank of America restated a "buy" rating and issued a $82.00 price objective (up from $80.00) on shares of Centene in a research report on Wednesday, October 28th. Raymond James Financial set a $79.00 price objective on shares of Centene in a research note on Wednesday, October 28th. Robert W. Baird lifted their target price on shares of Centene from $66.00 to $71.00 and gave the company a "neutral" rating in a report on Wednesday, October 28th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Centene from $67.00 to $75.00 and gave the company a "neutral" rating in a research note on Thursday, October 29th. Nine research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Centene currently has a consensus rating of "Hold" and an average price target of $73.80.

View Our Latest Stock Report on CNC

Centene Price Performance

NYSE:CNC opened at $70.17 on Wednesday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.69. Centene Corporation has a 52 week low of $31.63 and a 52 week high of $78.08. The stock's 50-day moving average price is $66.83 and its 200-day moving average price is $56.12. The stock has a market capitalization of $34.74 billion, a PE ratio of 24.03, a price-to-earnings-growth ratio of 0.40 and a beta of 1.07.

Centene (NYSE:CNC - Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.48. The company had revenue of $50.65 billion during the quarter, compared to analysts' expectations of $47.12 billion. Centene had a return on equity of 12.15% and a net margin of 0.72%. Centene's quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.50 EPS. As a group, equities analysts expect that Centene Corporation will post 5.27 EPS for the current fiscal year.

About Centene

(Free Report)

Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.

Read More

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC - Free Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Centene Right Now?

Before you consider Centene, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.

While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines